Purchase Order 75N95023P00411
Award Date 7/10/23
Potential Completion Date 8/10/24
Potential Value $455K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $552,500 firm fixed price purchase order by the National Institutes of Health National Institute on Aging to perform discovery-based proteomic assays on approximately 850 human plasma samples. The purpose is to identify molecular pathways that accelerate cognitive decline across stages of Alzheimer's disease, as requested in the solicitation titled "Predicting cognitive decline across the...
- The National Institute on Aging (NIA), Intramural Research Program (IRP), Translational Gerontology Branch (TGB) has awarded a firm-fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for the procurement of 16 SomaScan 11K kits. The contract has a ceiling value of $721,631.00 and an ultimate completion date of September 18, 2026. The award was made on September 19, 2025. Somalogic is a commercial-stage proteomics company based in Boulder,...
- Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $600,000 firm fixed price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services. The contract calls for Somalogic to provide SomaScan assay data for one thousand human serum samples using the SomaScan V4.1 serum platform. SomaScan is Somalogic's proprietary proteomics...
- Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $25,000 purchase order contract by the National Institutes of Health's National Institute on Aging to provide laboratory testing services for SOMASCAN discovery. The testing services will support the NIH/NIA's biomedical research efforts over a one-year period of performance in Boulder, Colorado. As the prime contractor, CM Life Sciences II Inc. will leverage its proteomics platform to analyze...
- This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The $152,200.00 contract is for the purchase and installation of SomaScan 7K protein biomarker assay kits and reagents. This work supports ongoing and developing proteomics research projects within the NIA's Translational Gerontology Branch and other laboratories, including...
- This is a firm-fixed-price purchase order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. The $24,975.00 contract is for laboratory support services to deliver 7,000 protein measurements from plasma samples using Somalogic's proprietary SomaScan Discovery V4.1 platform. The services are to be performed at Somalogic's facility in Boulder, Colorado, and...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $245,000.00 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for analysis using SomaScan assays. This is a commercial-stage proteomics company that provides protein biomarker discovery and diagnostic services through its proprietary SomaScan platform. The contract has no set-aside...
- This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.) for the provision of BIOLOGICAL MATERIAL - SOMASCAN 11K ASSAY V5.0 HUMAN PLASMA, NO SLIDE KIT. The contract has a ceiling value of $16,106.00 and a period of performance ending on October 31, 2025. Somalogic is a commercial-stage proteomics company that specializes in its...
- Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $242,725 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Somalogic will provide SomaScan 7K Assay kits for use in ongoing research analyzing clinical samples to study the immune system. Deliveries of the plasma, serum, urine, cerebral spinal fluid, cell and tissue...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., to provide SomaScan HTS assay kits for cell, tissue, human serum, and human plasma analysis. The $146,925 award supports proteomics research and clinical trials analyzing disease pathways and developing diagnostics. Somalogic is a...
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $455,000 firm fixed price purchase order from the National Institutes of Health's National Institute on Aging to examine the cerebral spinal fluid (CSF) and plasma proteome in Alzheimer's and chronic kidney disease. Through its proprietary SomaScan platform, Somalogic will supply aptamer-based assays and associated laboratory testing capable of measuring thousands of proteins in small-volume biosamples to support proteomics research analyzing disease pathways and developing diagnostics. Performance will take place in Boulder, Colorado through August 2024. No set-aside designation was utilized for this award.
Generated 1/23/24, 3:59 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 1/22/24 | |
| Not listed | Not listed | $455.0k | 7/10/23 |